Measurements for intervention and control groups
| Measurements for intervention and control groups | Baseline GW 24–28 | III trim GW 35–37 | Birth | Post partum (3 months) |
| o Background questionnaire | · | |||
| o OGTT | · | · | ||
| o Capillary glucose measurements | · | · | ||
| o Laboratory blood samples | · | · | · | |
| o Questionnaires* | · | · | · | |
| o Physical activity (UKK RM42 accelerometer) | · | · | · | |
| o Heart rate variability (Firstbeat Bodyguard 2) (analyses shown to participants only after postpartum visit) | · | · | · | |
| o Cord blood | · | |||
| o Placental weight | · | |||
| o Infant’s anthropometry (Pea Pod) | · | |||
| Measurements only for intervention group: | ||||
| One app week +3 normal care weeks repeatedly until delivery | |||
| o Usability questionnaire | · | |||
| o Semi-structured interview† | · | |||
*Questionnaires=Food Frequency Questionnaire (FFQ), depression, motivation and quality of life. At the postpartum study visit (3 months) FFQ and depression questionnaire.
†Twenty participants will conduct the semi-structured interview about the user experience with the eMOM GDM app
CGM, continuous glucose metre; GDM, gestational diabetes mellitus; GW, gestational week; OGTT, oral glucose tolerance test; UTAUT, Unified Theory of Acceptance and Use of Technology.